Premium
Administration of 8‐Hydroxy‐2‐(Di‐ n ‐Propylamino)tetralin in Raphe Nuclei Dorsalis and Medianus Reduces Serotonin Synthesis in the Rat Brain: Differences in Potency and Regional Sensitivity
Author(s) -
Invernizzi Roberto,
Carli Mirjana,
Clemente Angelo,
Samanin Rosario
Publication year - 1991
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.1991.tb02587.x
Subject(s) - serotonin , raphe , potency , 5 ht receptor , tetralin , biology , medicine , serotonergic , endocrinology , receptor , in vitro , biochemistry , catalysis
Following administration of 8‐hydroxy‐2‐(di‐ n ‐propylamino)tetralin (8‐OH‐DPAT; 0.04–5.0 μg/0.5 μl) in the raphe nucleus dorsalis (DR) or medianus (MR), the synthesis of serotonin (5‐HT), as assessed by the accumulation of 5‐hydroxytryptophan (5‐HTP) after decarboxylase inhibition, was measured in various regions of the rat CNS. At all doses, 8‐OH‐DPAT in the DR significantly reduced 5‐HTP accumulation in the striatum, nucleus accumbens, cortex, and prefrontal cortex, whereas even the highest dose had no effect in the hippocampus, hypothalamus, and spinal cord. One microgram of 8‐OH‐DPAT in the MR significantly reduced 5‐HTP accumulation in the nucleus accumbens and prefrontal cortex, and 5 μg had an effect in all the areas except the striatum and spinal cord. One and 5 μg of 8‐OH‐DPAT, administered in either the DR or MR, did not significantly modify the accumulation of dihydroxyphenylalanine in the striatum and nucleus accumbens. The results confirm that DR and MR have different sensitivities to 5‐HT 1A receptor agonists, and that activation of 5‐HT 1A receptors in these nuclei produces different effects on 5‐HT synthesis in different brain regions.